GOP

Military families hit with bitter blow after Congress strips fertility treatment funding from defense bill

More than eight years after my failed IUI, as federal employees have seen an expansion in their fertility benefits, TRICARE still doesn’t offer fertility coverage. A couple of weeks ago, it really looked like it would, which is why as we ring in 2026, I am thinking of the military families struggling to have a baby, for whom this new year will be off to a bitter start. They were banking on a provision in the massive defense bill signed into law by President Donald Trump just before the holidays that would have given them the same kind of access to fertility…
Read More

Trump Administration Quietly Bans Abortions for Veterans—Even After Rape or When Health is in Danger

The Trump Administration has confirmed it is no longer providing abortion care for veterans relying on VA health care even in instances of rape, incest, or to save the health of the pregnant person. While veterans and their family members were previously able to to access abortion care in these specific circumstances, this new policy offers only a narrow and vague exception to save the life of a pregnant veteran or their family member. These kinds of exceptions to save a person’s life often don’t work in reality.   
Read More

Privacy concerns linger in reproductive health care despite HIPAA lawsuit’s dismissal

A Biden-era protection for reproductive and gender affirming health care information was upended by a federal judge in Texas in June. Despite several lawsuits, key privacy rules for medical records remain, but some experts say they aren’t sufficient. (Photo by Dave Whitney / Getty Images)The four lawsuits at the center of a Republican-led effort to ensure law enforcement can access reproductive health records are now mostly resolved, after attorneys for Texas Attorney General Ken Paxton agreed last week to dismiss the last remaining suit challenging the legality of a foundational health privacy rule.
Read More

Understanding the Trump Administration’s Negotiated Drug Prices for Medicare

The Centers for Medicare & Medicaid Services (CMS) has just announced the prices that the federal government negotiated for 15 high-cost drugs covered by Part D, Medicare’s prescription drug benefit program, including the popular diabetes and obesity drugs Ozempic and Wegovy. This brings to a close the second round of Medicare’s Drug Price Negotiation Program, which was created by the Inflation Reduction Act of 2022 under the Biden administration. These negotiated prices will take effect in Medicare in January 2027.
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.